mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for HSD17B8
Gene summary
Basic gene Info.Gene symbolHSD17B8
Gene namehydroxysteroid (17-beta) dehydrogenase 8
SynonymsD6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9
CytomapUCSC genome browser: 6p21.3
Type of geneprotein-coding
RefGenesNM_014234.4,
Description17-beta-HSD 817-beta-hydroxysteroid dehydrogenase 83-oxoacyl-[acyl-carrier-protein] reductaseestradiol 17-beta-dehydrogenase 8estrogen 17-oxidoreductaseke-6protein Ke6really interesting new gene 2 proteinshort chain dehydrogenase/reductase family
Modification date20141207
dbXrefs MIM : 601417
HGNC : HGNC
Ensembl : ENSG00000204228
HPRD : 03248
Vega : OTTHUMG00000031117
ProteinUniProt: Q92506
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_HSD17B8
BioGPS: 7923
PathwayNCI Pathway Interaction Database: HSD17B8
KEGG: HSD17B8
REACTOME: HSD17B8
Pathway Commons: HSD17B8
ContextiHOP: HSD17B8
ligand binding site mutation search in PubMed: HSD17B8
UCL Cancer Institute: HSD17B8
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006703estrogen biosynthetic process17978863


Top
Ligand binding site mutations for HSD17B8

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
T207K209RKIRC1
Y169,K173A171SOV1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for HSD17B8
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
K173A171S-1.1377324
Y169A171S-1.1377324
T207K209R-0.34769809
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for HSD17B8 from PDB

Top
Differential gene expression and gene-gene network for HSD17B8
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of HSD17B8 and the right PPI network was created from samples without mutations in the LBS of HSD17B8. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for HSD17B8
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for HSD17B8
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
NutraceuticalDB00157NADHSmall molecule
ExperimentalDB034612'-Monophosphoadenosine 5'-DiphosphoriboseSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of HSD17B8 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NADNAD ZWITTERION2pd6AY169 K173
NADNAD ZWITTERION4cqlAY169 K173
NADNAD ZWITTERION4cqlHY169 K173
NADNAD ZWITTERION4cqlLY169 K173
NADNAD ZWITTERION4cqlMY169 K173
NADNAD ZWITTERION4cqlPY169 K173
NADNAD ZWITTERION2pd6BY169 K173 T207
NADNAD ZWITTERION2pd6CY169 K173 T207
NADNAD ZWITTERION2pd6DY169 K173 T207
NADNAD ZWITTERION4cqlDY169 K173 T207
NADNAD ZWITTERION4cqlEY169 K173 T207
NADNAD ZWITTERION4cqlIY169 K173 T207
NAPNADP ZWITTERION4cqmAY169 K173 T207
NAPNADP ZWITTERION4cqmDY169 K173 T207
NAPNADP ZWITTERION4cqmEY169 K173 T207
NAPNADP ZWITTERION4cqmHY169 K173 T207
NAPNADP ZWITTERION4cqmIY169 K173 T207
NAPNADP ZWITTERION4cqmLY169 K173 T207
NAPNADP ZWITTERION4cqmMY169 K173 T207
NAPNADP ZWITTERION4cqmPY169 K173 T207


Top
Conservation information for LBS of HSD17B8
Multiple alignments for Q92506 in multiple species
LBSAA sequence# speciesSpecies
A104VVVSCAGITRD2Mus musculus, Rattus norvegicus
A104VVVSCAGITQD1Homo sapiens
A74HAAFQADVSEA1Homo sapiens
A74HAAFQADVSQG1Mus musculus
A74HAAFQADVSEG1Rattus norvegicus
C103SVVVSCAGITR2Mus musculus, Rattus norvegicus
C103SVVVSCAGITQ1Homo sapiens
D42AVAACDLDGAA2Mus musculus, Rattus norvegicus
D42TVAACDLDRAA1Homo sapiens
D44AACDLDGAAAQ2Mus musculus, Rattus norvegicus
D44AACDLDRAAAQ1Homo sapiens
D75AAFQADVSEAR1Homo sapiens
D75AAFQADVSQGP1Mus musculus
D75AAFQADVSEGP1Rattus norvegicus
F201SVLPGFIATPM3Homo sapiens, Mus musculus, Rattus norvegicus
G105VVSCAGITRDE2Mus musculus, Rattus norvegicus
G105VVSCAGITQDE1Homo sapiens
G18LALVTGAGSGI3Homo sapiens, Mus musculus, Rattus norvegicus
G200NSVLPGFIATP3Homo sapiens, Mus musculus, Rattus norvegicus
G22TGAGSGIGRAI2Mus musculus, Rattus norvegicus
G22TGAGSGIGRAV1Homo sapiens
I106VSCAGITRDEF2Mus musculus, Rattus norvegicus
I106VSCAGITQDEF1Homo sapiens
I154GSIINISSIVG2Homo sapiens, Rattus norvegicus
I154GSIINISSIIG1Mus musculus
I202VLPGFIATPMT3Homo sapiens, Mus musculus, Rattus norvegicus
I23GAGSGIGRAIS2Mus musculus, Rattus norvegicus
I23GAGSGIGRAVS1Homo sapiens
K173NYASSKAGVIG2Mus musculus, Rattus norvegicus
K173NYAASKAGVIG1Homo sapiens
L43VAACDLDGAAA2Mus musculus, Rattus norvegicus
L43VAACDLDRAAA1Homo sapiens
M206FIATPMTQKMP2Mus musculus, Rattus norvegicus
M206FIATPMTQKVP1Homo sapiens
P199CNSVLPGFIAT3Homo sapiens, Mus musculus, Rattus norvegicus
P205GFIATPMTQKM2Mus musculus, Rattus norvegicus
P205GFIATPMTQKV1Homo sapiens
S155SIINISSIVGK2Homo sapiens, Rattus norvegicus
S155SIINISSIIGK1Mus musculus
S156IINISSIVGKV2Homo sapiens, Rattus norvegicus
S156IINISSIIGKV1Mus musculus
S21VTGAGSGIGRA3Homo sapiens, Mus musculus, Rattus norvegicus
S77FQADVSEARAA1Homo sapiens
S77FQADVSQGPAA1Mus musculus
S77FQADVSEGPAA1Rattus norvegicus
T204PGFIATPMTQK3Homo sapiens, Mus musculus, Rattus norvegicus
T207IATPMTQKMPE2Mus musculus, Rattus norvegicus
T207IATPMTQKVPQ1Homo sapiens
V126DRVIAVNLKGT2Mus musculus, Rattus norvegicus
V126DKVIAVNLKGT1Homo sapiens
V76AFQADVSEARA1Homo sapiens
V76AFQADVSQGPA1Mus musculus
V76AFQADVSEGPA1Rattus norvegicus
Y169IGQTNYASSKA2Mus musculus, Rattus norvegicus
Y169VGQTNYAASKA1Homo sapiens


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas